This #MultipleMyelomaAwarenessMonth, read about @szusmani.bsky.social's vision for developing new treatment approaches at MSK that will improve #mm outcome: bit.ly/3DAzQkt
Multiple Myeloma: Improved Prognosis With the Latest Treatments
Learn how multiple myeloma prognosis has improved significantly with the emergence of new drug treatments.
www.mskcc.org
March 17, 2025 at 5:01 PM
This #MultipleMyelomaAwarenessMonth, read about @szusmani.bsky.social's vision for developing new treatment approaches at MSK that will improve #mm outcome: bit.ly/3DAzQkt
When Kellie was diagnosed with multiple myeloma, her husband, Yaphet “wanted to do anything to help find a cure.” He decided to participate in #StandUpToCancer’s clinical trial, THE PROMISE Study. Read more: bit.ly/43A2X1B. #MultipleMyelomaAwarenessMonth
March 20, 2025 at 4:10 PM
When Kellie was diagnosed with multiple myeloma, her husband, Yaphet “wanted to do anything to help find a cure.” He decided to participate in #StandUpToCancer’s clinical trial, THE PROMISE Study. Read more: bit.ly/43A2X1B. #MultipleMyelomaAwarenessMonth
CU Cancer Center researchers and physicians are world leaders in blood cancers like multiple myeloma and the best in the Rocky Mountain region for stem cell transplant outcomes.
Learn more about multiple myeloma: buff.ly/4kbuEnk
#MultipleMyelomaAwarenessMonth
Learn more about multiple myeloma: buff.ly/4kbuEnk
#MultipleMyelomaAwarenessMonth
March 3, 2025 at 7:23 PM
CU Cancer Center researchers and physicians are world leaders in blood cancers like multiple myeloma and the best in the Rocky Mountain region for stem cell transplant outcomes.
Learn more about multiple myeloma: buff.ly/4kbuEnk
#MultipleMyelomaAwarenessMonth
Learn more about multiple myeloma: buff.ly/4kbuEnk
#MultipleMyelomaAwarenessMonth
This #MultipleMyelomaAwarenessMonth, learn about how center scientist Dr. Lili Yang is developing a new treatment approach using CAR-iNKT cells that could improve patient outcomes.
UCLA scientists develop novel technology that positions ‘off-the-shelf’ cancer immunotherapy for the clinic
Immunotherapies have revolutionized cancer treatment by harnessing the body’s own immune system to attack cancer cells and halt tumor growth. However, these therapies often need to be tailored to each...
stemcell.ucla.edu
March 17, 2025 at 6:45 PM
This #MultipleMyelomaAwarenessMonth, learn about how center scientist Dr. Lili Yang is developing a new treatment approach using CAR-iNKT cells that could improve patient outcomes.
📢 Understanding Relapsed Multiple Myeloma #MultipleMyelomaAwarenessMonth🩸
🔎 Stay informed on the latest #research, treatment strategies and expert insights to navigate the evolving #Myeloma landscape
📲 Explore more on our Multiple Myeloma channel 👉 buff.ly/40tGnGb
🔎 Stay informed on the latest #research, treatment strategies and expert insights to navigate the evolving #Myeloma landscape
📲 Explore more on our Multiple Myeloma channel 👉 buff.ly/40tGnGb
March 17, 2025 at 9:29 AM
📢 Understanding Relapsed Multiple Myeloma #MultipleMyelomaAwarenessMonth🩸
🔎 Stay informed on the latest #research, treatment strategies and expert insights to navigate the evolving #Myeloma landscape
📲 Explore more on our Multiple Myeloma channel 👉 buff.ly/40tGnGb
🔎 Stay informed on the latest #research, treatment strategies and expert insights to navigate the evolving #Myeloma landscape
📲 Explore more on our Multiple Myeloma channel 👉 buff.ly/40tGnGb
March is #MultipleMyelomaAwarenessMonth. AACR Project GENIE offers valuable insights into the genomic landscape of multiple myeloma, with 1,167 patients and 1,548 sequenced tumor samples. #AACRGENIE: www.aacr.org/professional... Powering the future of precision oncology.
March 23, 2025 at 10:07 PM
March is #MultipleMyelomaAwarenessMonth. AACR Project GENIE offers valuable insights into the genomic landscape of multiple myeloma, with 1,167 patients and 1,548 sequenced tumor samples. #AACRGENIE: www.aacr.org/professional... Powering the future of precision oncology.
Tailoring Treatment for Newly Diagnosed #Myeloma🩸#MultipleMyelomaAwarenessMonth
With #myeloma treatment evolving rapidly, a one-size-fits-all approach is no longer enough. Dr. Paul Richardson shares his insights on how #precisionmedicine is shaping frontline #myeloma care
🔗 buff.ly/4bmGh7b 🔗
With #myeloma treatment evolving rapidly, a one-size-fits-all approach is no longer enough. Dr. Paul Richardson shares his insights on how #precisionmedicine is shaping frontline #myeloma care
🔗 buff.ly/4bmGh7b 🔗
March 10, 2025 at 9:29 AM
Tailoring Treatment for Newly Diagnosed #Myeloma🩸#MultipleMyelomaAwarenessMonth
With #myeloma treatment evolving rapidly, a one-size-fits-all approach is no longer enough. Dr. Paul Richardson shares his insights on how #precisionmedicine is shaping frontline #myeloma care
🔗 buff.ly/4bmGh7b 🔗
With #myeloma treatment evolving rapidly, a one-size-fits-all approach is no longer enough. Dr. Paul Richardson shares his insights on how #precisionmedicine is shaping frontline #myeloma care
🔗 buff.ly/4bmGh7b 🔗
In honor of #MultipleMyelomaAwarenessMonth 🩸, get to know our active #myeloma trials! EAA181/EQUATE is a randomized phase 3 trial for newly diagnosed #MultipleMyeloma patients. Learn more here: bit.ly/eaa181equate #mmsm cc: @vincentrk.bsky.social
March 4, 2025 at 2:49 PM
In honor of #MultipleMyelomaAwarenessMonth 🩸, get to know our active #myeloma trials! EAA181/EQUATE is a randomized phase 3 trial for newly diagnosed #MultipleMyeloma patients. Learn more here: bit.ly/eaa181equate #mmsm cc: @vincentrk.bsky.social
🔎How are we redefining #highriskmyeloma—and what does this mean for treatment? #MultipleMyelomaAwarenessMonth🩸
Dr Karthik Ramasamy discusses key mutational changes in #TP53 & #biallelicalterations and why they're critical to understanding high-risk disease
👉 buff.ly/3EJQyxN
Dr Karthik Ramasamy discusses key mutational changes in #TP53 & #biallelicalterations and why they're critical to understanding high-risk disease
👉 buff.ly/3EJQyxN
March 24, 2025 at 9:29 AM
🔎How are we redefining #highriskmyeloma—and what does this mean for treatment? #MultipleMyelomaAwarenessMonth🩸
Dr Karthik Ramasamy discusses key mutational changes in #TP53 & #biallelicalterations and why they're critical to understanding high-risk disease
👉 buff.ly/3EJQyxN
Dr Karthik Ramasamy discusses key mutational changes in #TP53 & #biallelicalterations and why they're critical to understanding high-risk disease
👉 buff.ly/3EJQyxN
Could #MRD-Guided Therapy De-Escalation Change Treatment? #MultipleMyelomaAwarenessMonth🩸
Elena Zamagni, MD, PhD explores the potential of MRD-driven therapy adjustments, discussing how this evolving approach could transform patient management in the future
📺 Watch to learn more! 👉 buff.ly/3CYZ8bx
Elena Zamagni, MD, PhD explores the potential of MRD-driven therapy adjustments, discussing how this evolving approach could transform patient management in the future
📺 Watch to learn more! 👉 buff.ly/3CYZ8bx
March 28, 2025 at 9:29 AM
Could #MRD-Guided Therapy De-Escalation Change Treatment? #MultipleMyelomaAwarenessMonth🩸
Elena Zamagni, MD, PhD explores the potential of MRD-driven therapy adjustments, discussing how this evolving approach could transform patient management in the future
📺 Watch to learn more! 👉 buff.ly/3CYZ8bx
Elena Zamagni, MD, PhD explores the potential of MRD-driven therapy adjustments, discussing how this evolving approach could transform patient management in the future
📺 Watch to learn more! 👉 buff.ly/3CYZ8bx
So it’s March, which means it’s #MultipleMyelomaAwarenessMonth… unless, of course, you have #multiplemyeloma. Then, every month is Multiple Myeloma Awareness Month. Whee!
March 4, 2025 at 4:15 PM
So it’s March, which means it’s #MultipleMyelomaAwarenessMonth… unless, of course, you have #multiplemyeloma. Then, every month is Multiple Myeloma Awareness Month. Whee!